{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:45:45Z","timestamp":1793151945155,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.critrevonc.2016.10.006","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T16:17:13Z","timestamp":1477153033000},"page":"86-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Dendritic cells in hematological malignancies"],"prefix":"10.1016","volume":"108","author":[{"given":"Domenico","family":"Galati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Corazzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"De Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2016.10.006_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1615\/JEnvironPatholToxicolOncol.2013007930","article-title":"The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma","volume":"32","author":"Abdou","year":"2013","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","article-title":"The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape","volume":"221","author":"Aldinucci","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0015","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.164.4.1855","article-title":"Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells","volume":"164","author":"Anderson","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0020","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20061120","article-title":"Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development","volume":"204","author":"Aspord","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0025","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/leu.2013.310","article-title":"Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma","volume":"28","author":"Atanackovic","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0040","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2004-10-3991","article-title":"Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction","volume":"106","author":"Bertho","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0045","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403474","article-title":"Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate","volume":"18","author":"Boissel","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20141441","article-title":"Circulating precursors of human CD1c+ and CD141+ dendritic cells","volume":"212","author":"Breton","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03037.x","article-title":"Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma","volume":"144","author":"Brimnes","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0060","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-04-019711","article-title":"Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function","volume":"109","author":"Brogdon","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0065","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","article-title":"Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10","volume":"98","author":"Brown","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0070","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3109\/10428194.2011.569619","article-title":"Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma","volume":"52","author":"Butsch","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sj.cdd.4402235","article-title":"The \u2018kiss of death' by dendritic cells to cancer cells","volume":"15","author":"Chan","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0080","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":"Identification of a leukemic counterpart of the plasmacytoid dendritic cells","volume":"97","author":"Chaperot","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0085","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/eji.200324531","article-title":"Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts","volume":"34","author":"Chaperot","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4049\/jimmunol.176.1.248","article-title":"Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells","volume":"176","author":"Chaperot","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-14-335","article-title":"Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study","volume":"14","author":"Choe","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2559.2011.03967.x","article-title":"Type and maturational status of dendritic cells in cutaneous B cell lymphoproliferative disorders","volume":"59","author":"Christie","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1189\/jlb.0307166","article-title":"Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells","volume":"82","author":"Cools","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0110","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1189\/jlb.1103532","article-title":"Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes","volume":"78","author":"Cox","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0115","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1158\/0008-5472.CAN-04-1272","article-title":"Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer","volume":"64","author":"Curiel","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1705183","article-title":"Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival","volume":"36","author":"Dean","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/sji.12223","article-title":"Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia","volume":"80","author":"Derolf","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-71029-5_1","article-title":"Activation of dendritic cells by toll-like receptors and C-type lectins","author":"Diebold","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0135","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/14653240410006004","article-title":"Impaired circulating myeloid DCs from myeloma patients","volume":"6","author":"Do","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0145","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1182\/blood-2002-06-1841","article-title":"Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration","volume":"101","author":"Dong","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fimmu.2013.00438","article-title":"Immature, semi-mature, and fully mature dendritic cells: toward a DC-Cancer cells interface that augments anticancer immunity","volume":"4","author":"Dudek","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10428190500360971","article-title":"Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L","volume":"47","author":"Fiore","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","article-title":"Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients","volume":"124","author":"Frankel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.it.2008.02.002","article-title":"Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies","volume":"29","author":"Fujii","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.2006.06458.x","article-title":"Plasmacytoid dendritic cell leukaemia\/lymphoma: towards a well defined entity","volume":"136","author":"Garnache-Ottou","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0180","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","article-title":"Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL","volume":"189","author":"Griffith","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1100066","article-title":"IRF8 mutations and human dendritic-cell immunodeficiency","volume":"365","author":"Hambleton","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2012.04.012","article-title":"Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells","volume":"37","author":"Haniffa","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0195","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1073\/pnas.0707244104","article-title":"HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha","volume":"104","author":"Hardy","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0200","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1080\/10428190802464729","article-title":"Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy","volume":"49","author":"Harrison","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0205","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/S1470-2045(15)70103-8","article-title":"Programmed cell death-1 inhibition in lymphoma","volume":"16","author":"Hawkes","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2141.2004.04956.x","article-title":"Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals","volume":"125","author":"Hishizawa","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0215","first-page":"105","article-title":"Dendritic cell distribution in lymphomas","volume":"31","author":"Hussin","year":"2009","journal-title":"Malays. J. Pathol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0220","doi-asserted-by":"crossref","first-page":"16693","DOI":"10.1074\/jbc.M709923200","article-title":"CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes","volume":"283","author":"Huysamen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0225","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0230","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev.immunol.21.120601.141007","article-title":"Biology of hematopoietic stem cells and progenitors: implications for clinical application","volume":"21","author":"Kondo","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2016.03.022","article-title":"Blastic plasmacytoid dendritic cell neoplasm: from origin of the cell to targeted therapies","author":"Laribi","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0240","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1084\/jem.20092720","article-title":"Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC","volume":"207","author":"Lauterbach","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.20141442","article-title":"Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow","volume":"212","author":"Lee","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0250","doi-asserted-by":"crossref","first-page":"e44266","DOI":"10.1371\/journal.pone.0044266","article-title":"CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells","volume":"7","author":"Lichtenegger","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0255","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/IGC.0b013e31825401c6","article-title":"Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma","volume":"22","author":"Lijun","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1179\/102453312X13221316477453","article-title":"Generation of lymphocytes potentiated against leukemic lymphoblasts by stimulation using leukemic cell lysate-pulsed dendritic cells in patients with acute lymphoblastic leukemia and measurement of in vitro anti-leukemic cytotoxicity","volume":"17","author":"Lim","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.imlet.2009.09.003","article-title":"Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth","volume":"127","author":"Lin","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physrev.00023.2001","article-title":"Dendritic cells: immune regulators in health and disease","volume":"82","author":"Lipscomb","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0275","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.4049\/jimmunol.166.9.5407","article-title":"The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells","volume":"166","author":"Liu","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0280","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1126\/science.1170540","article-title":"In vivo analysis of dendritic cell development and homeostasis","volume":"324","author":"Liu","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0285","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.4049\/jimmunol.1300714","article-title":"Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesis","volume":"191","author":"Liu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-199707000-00001","article-title":"Getting to the Source: dendritic cells as therapeutic reagents for the treatment of patients with cancer","volume":"226","author":"Lotze","year":"1997","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0295","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.4049\/jimmunol.168.4.1831","article-title":"Innate direct anticancer effector function of human immature dendritic cells II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand","volume":"168","author":"Lu","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0300","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1471-4906(02)02281-0","article-title":"Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity","volume":"23","author":"Lutz","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0305","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.leu.2403430","article-title":"Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes","volume":"18","author":"Ma","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0310","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.leukres.2006.11.007","article-title":"Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile","volume":"31","author":"Ma","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0315","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.semcancer.2012.02.010","article-title":"Tumor associated regulatory dendritic cells","volume":"22","author":"Ma","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0320","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/10428190601101001","article-title":"Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission","volume":"48","author":"Maggio","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0325","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1440-1711.2002.01115.x","article-title":"but not inactive: the tolerogenic function of immature dendritic cells","volume":"80","author":"Mahnke","year":"2002","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/viro.2000.0445","article-title":"Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia","volume":"274","author":"Makino","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2004.04989.x","article-title":"Blood dendritic cells in patients with acute lymphoblastic leukaemia","volume":"126","author":"Mami","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0340","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.imbio.2007.11.009","article-title":"Blood dendritic cells in patients with chronic lymphocytic leukaemia","volume":"213","author":"Mami","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0345","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01015.x","article-title":"Dendritic cell control of tolerogenic responses","volume":"241","author":"Manicassamy","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0350","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1189\/jlb.72.2.312","article-title":"Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro","volume":"72","author":"Manna","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0355","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood.V96.3.878","article-title":"In vivo generation of human dendritic cell subsets by Flt3 ligand","volume":"96","author":"Maraskovsky","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00002371-200205000-00011","article-title":"Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells","volume":"25","author":"Marroquin","year":"2002","journal-title":"J. Immunother."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0365","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.18632\/oncotarget.4146","article-title":"Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile","volume":"6","author":"Martin-Martin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0370","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/leu.2008.49","article-title":"The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal\/reactive and myelodysplastic syndrome precursors","volume":"22","author":"Matarraz","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0375","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1158\/2326-6066.CIR-13-0102","article-title":"Dendritic cells: master regulators of the immune response","volume":"1","author":"Mellman","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0380","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0385","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2141.2004.05132.x","article-title":"Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome","volume":"126","author":"Micheva","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0390","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood.V98.13.3750","article-title":"Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment","volume":"98","author":"Mohty","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2141.2002.03831.x","article-title":"Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+\/CD38- primitive haematopoietic progenitors","volume":"119","author":"Mohty","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0400","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.leu.2402706","article-title":"Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia","volume":"16","author":"Mohty","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0405","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/blood-2003-09-3220","article-title":"Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia","volume":"103","author":"Mohty","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0410","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.4049\/jimmunol.175.12.7905","article-title":"CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells","volume":"175","author":"Morelli","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0415","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells","volume":"173","author":"Moseman","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0420","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/0008-5472.CAN-03-2969","article-title":"Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma","volume":"64","author":"Movassagh","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0425","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/eji.200535298","article-title":"Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells","volume":"36","author":"Nencioni","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0430","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood-2005-08-3494","article-title":"Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation","volume":"108","author":"Nencioni","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions","volume":"21","author":"Ohl","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0440","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.leukres.2005.11.028","article-title":"Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation","volume":"30","author":"Orsini","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0445","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1182\/blood.V100.8.2858","article-title":"Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes","volume":"100","author":"Osugi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0450","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2141.1997.3123128.x","article-title":"Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors","volume":"98","author":"Pfeiffer","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0455","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1711.2005.01371.x","article-title":"Dendritic cell dysfunction in cancer: a mechanism for immunosuppression","volume":"83","author":"Pinzon-Charry","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0460","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1182\/blood-2012-01-406967","article-title":"DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues","volume":"119","author":"Poulin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0465","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bbmt.2010.01.013","article-title":"Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant","volume":"16","author":"Rajasekar","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0470","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.V93.5.1487","article-title":"Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences","volume":"93","author":"Raje","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0475","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.immuni.2005.04.007","article-title":"The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function","volume":"22","author":"Rathinam","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0480","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0485","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2015.11","article-title":"Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells","volume":"29","author":"Ray","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0490","first-page":"2562","article-title":"Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice","volume":"118","author":"Reddy","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0495","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/1097-0142(20010601)91:11<2136::AID-CNCR1242>3.0.CO;2-Q","article-title":"The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma","volume":"91","author":"Reichert","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0500","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Reis e Sousa","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0505","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-031210-101345","article-title":"Plasmacytoid dendritic cells: recent progress and open questions","volume":"29","author":"Reizis","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0510","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2010.01.005","article-title":"Regulation of plasmacytoid dendritic cell development","volume":"22","author":"Reizis","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0515","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.leukres.2012.10.010","article-title":"Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes","volume":"37","author":"Saft","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0520","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/j.1349-7006.2008.00907.x","article-title":"Combined mobilization and stimulation of tumor-infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL-18 in vivo induces systemic antitumor immunity","volume":"99","author":"Saito","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0525","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature07750","article-title":"Identification of a dendritic cell receptor that couples sensing of necrosis to immunity","volume":"458","author":"Sancho","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0530","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2014.64","article-title":"Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition","volume":"28","author":"Sapienza","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0535","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2012.00274","article-title":"Regulatory dendritic cells: there is more than just immune activation","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0540","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1182\/blood-2011-08-373944","article-title":"The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells","volume":"119","author":"Schreibelt","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0545","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2340\/00015555-1220","article-title":"Distribution and maturation of skin dendritic cell subsets in two forms of cutaneous T-cell lymphoma: mycosis fungoides and Sezary syndrome","volume":"92","author":"Schwingshackl","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0550","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0555","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5858\/arpa.2013-0101-RS","article-title":"Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review","volume":"138","author":"Shi","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0560","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri1996","article-title":"Steady-state and inflammatory dendritic-cell development","volume":"7","author":"Shortman","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0570","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10555-006-9010-6","article-title":"Intratumoral cytokines\/chemokines\/growth factors and tumor infiltrating dendritic cells: friends or enemies","volume":"25","author":"Shurin","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0575","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/leu.2010.244","article-title":"HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells","volume":"25","author":"Song","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0580","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.192.12.1775","article-title":"Uittenbogaart CH. Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2","volume":"192","author":"Spits","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0585","doi-asserted-by":"crossref","first-page":"e0139867","DOI":"10.1371\/journal.pone.0139867","article-title":"PDL1 expression on plasma and dendritic cells in myeloma bone marrow suggests benefit of targeted anti PD1-PDL1 therapy","volume":"10","author":"Sponaas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0590","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0595","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment","volume":"29","author":"Steidl","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0600","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0605","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1084\/jem.141.4.804","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice: IV. Identification and distribution in mouse spleen","volume":"141","author":"Steinman","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0615","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0620","doi-asserted-by":"crossref","first-page":"e114345","DOI":"10.1371\/journal.pone.0114345","article-title":"Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma","volume":"9","author":"Tudor","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0625","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.167.7.3765","article-title":"Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand","volume":"167","author":"Vidalain","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0630","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1046\/j.1365-2141.1999.01431.x","article-title":"Dendritic cells in chronic myelomonocytic leukaemia","volume":"105","author":"Vuckovic","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0635","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.immuni.2007.06.006","article-title":"Development of dendritic-cell lineages","volume":"26","author":"Wu","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0640","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1074-7613(00)80370-2","article-title":"Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage","volume":"7","author":"Wu","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2016.10.006_bib0645","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281630258X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281630258X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T03:58:22Z","timestamp":1718855902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084281630258X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":129,"alternative-id":["S104084281630258X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.10.006","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells in hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}